BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26551737)

  • 21. Role of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma.
    Arii S
    J Hepatol; 2004 Aug; 41(2):333-5. PubMed ID: 15382329
    [No Abstract]   [Full Text] [Related]  

  • 22. VEGFR-1 activation-induced MMP-9-dependent invasion in hepatocellular carcinoma.
    Li T; Zhu Y; Han L; Ren W; Liu H; Qin C
    Future Oncol; 2015; 11(23):3143-57. PubMed ID: 26551737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome.
    Laird A; O'Mahony FC; Nanda J; Riddick AC; O'Donnell M; Harrison DJ; Stewart GD
    PLoS One; 2013; 8(4):e60483. PubMed ID: 23577117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
    Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
    J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells.
    Yi ZY; Feng LJ; Xiang Z; Yao H
    J Invest Surg; 2011; 24(2):67-76. PubMed ID: 21345006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition.
    Lin CY; Tsai PH; Kandaswami CC; Lee PP; Huang CJ; Hwang JJ; Lee MT
    Cancer Sci; 2011 Apr; 102(4):815-27. PubMed ID: 21219539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A three-dimensional cell biology model of human hepatocellular carcinoma in vitro.
    Tang J; Cui J; Chen R; Guo K; Kang X; Li Y; Gao D; Sun L; Xu C; Chen J; Tang Z; Liu Y
    Tumour Biol; 2011 Jun; 32(3):469-79. PubMed ID: 21140254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1).
    Schwartz JD; Rowinsky EK; Youssoufian H; Pytowski B; Wu Y
    Cancer; 2010 Feb; 116(4 Suppl):1027-32. PubMed ID: 20127948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma.
    Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C
    Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer.
    Hipp S; Walch A; Schuster T; Losko S; Laux H; Bolton T; Höfler H; Becker KF
    J Cell Mol Med; 2009 Sep; 13(9B):3858-67. PubMed ID: 19604315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature.
    Köhrmann A; Kammerer U; Kapp M; Dietl J; Anacker J
    BMC Cancer; 2009 Jun; 9():188. PubMed ID: 19531263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells.
    Zhang S; Li J; Jiang Y; Xu Y; Qin C
    J Exp Clin Cancer Res; 2009 May; 28(1):71. PubMed ID: 19480673
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.